Form 4: CONMED Corp Executive Acquires 33,508 Stock Options

Heather L. Cohen, EVP & Chief HR & Legal Officer of CONMED Corp, acquired 33,508 stock options on March 1, 2024, under the company's 2018 Long-Term Incentive Plan.

Summary

• On March 1, 2024, Heather L. Cohen, EVP & Chief HR & Legal Officer of CONMED Corp, acquired 33,508 stock options.
• The options were granted under the company's 2018 Long-Term Incentive Plan.
• The exercise price of the options is $79.95.
• The options generally vest in equal amounts over a five-year period.
• The expiration date for the options is March 1, 2034.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to executive compensation. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Positives

• The grant of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

This is a standard practice for incentivizing executives in publicly traded companies. Stock options are a common component of executive compensation packages in the medical device industry.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in publicly traded companies, including those in the medical device industry like CONMED Corp.
• Companies such as Stryker, Johnson & Johnson, and Medtronic also utilize stock options as part of their executive compensation plans to align management's interests with those of shareholders.

Stakeholder Impact

• The stock option grant could potentially incentivize the executive to improve company performance, benefiting shareholders.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates